Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes

NCT01454687 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01454687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01454687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2011
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa